# 2026 ACC/AHA multisociety guideline on the management of dyslipidemia Guideline · id `cardio:guideline-acc-aha-2026-dyslipidemia` · Cardiovascular Atlas · release `5dcd9b263fe17744` (public) > General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations. Also called: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia Browse, organ or system: Heart; Blood vessels Browse, condition area: Risk and prevention; Coronary and vascular disease ## In plain language The 2026 guideline from the American College of Cardiology and the American Heart Association, with other societies named in its title, on managing dyslipidemia: high blood cholesterol, high triglycerides and elevated lipoprotein(a). Its abstract says it replaces the 2018 guideline on blood cholesterol. Only the abstract could be read, so this page gives no thresholds, targets or recommendations. ## Technical summary Circulation 2026;153(17):e1154-e1276, doi 10.1161/CIR.0000000000001423, PMID 41824552. Electronic publication 2026-03-13. Issued by the joint ACC/AHA committee on clinical practice guidelines. The title names nine more societies by abbreviation; the abbreviations alone do not tie them to records in this atlas, so only the ACC and the AHA are linked as issuers. The abstract does not name the risk equation the guideline uses. PubMed lists two corrections (2026-06-23 and 2026-09-08); their text was not read. ## Claims, with the population each applies to ## Context: Individuals with dyslipidemia (2026 ACC/AHA multisociety guideline) Recipient: Recipient not specified; Population: Individuals with dyslipidemias, which the abstract lists as high blood cholesterol, high triglycerides and elevated lipoprotein(a). The abstract gives no age limits and no inclusion or exclusion criteria.; Care setting: Not stated in the abstract. The abstract says the guideline covers evaluation, management and monitoring.; Geography: Not stated in the abstract (issued by American societies; jurisdiction not verified); Life stage: Not stated in the abstract; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (guideline context) ### The abstract of the 2026 ACC/AHA multisociety dyslipidemia guideline says it retires and replaces the 2018 guideline on managing blood cholesterol. It says the guideline addresses evaluation, management and monitoring of people with high blood cholesterol, high triglycerides and elevated lipoprotein(a). - Category: Description - Evidence stage: Guidance - Certainty: Certainty not assessed - Applies to: Recipient: Recipient not specified; Population: Individuals with dyslipidemias, which the abstract lists as high blood cholesterol, high triglycerides and elevated lipoprotein(a). The abstract gives no age limits and no inclusion or exclusion criteria.; Care setting: Not stated in the abstract. The abstract says the guideline covers evaluation, management and monitoring.; Geography: Not stated in the abstract (issued by American societies; jurisdiction not verified); Life stage: Not stated in the abstract; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (guideline context) - Limitations: Only the abstract and the bibliographic record were read, so no threshold, target, medicine or class of recommendation from the guideline is recorded. PubMed lists two corrections to the guideline (2026-06-23 and 2026-09-08); their text was not read, so it is not known whether they change anything the abstract says. This claim states the replacement. It does not link to a record of the 2018 guideline. - Last checked: 2026-10-15 - Source problem: a cited source is corrected. Check the sources before relying on this claim. - Sources: 1. Supports: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (Guideline, edition Published in Circulation 153(17):e1154-e1276 (issue date 2026-04-28; electronic publication 2026-03-13). PubMed abstract and bibliographic data only. The guideline text was not read. PubMed lists 2 corrections to the guideline; their text was not read. The publisher field is the journal title as PubMed gives it.) Locator: Abstract, AIM. Retrieved 2026-10-15T13:48:57Z. Source state: Corrected. Snapshot hash: afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff. How it applies: The guideline retires and replaces the 2018 blood cholesterol guideline. 2. Supports: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (Guideline, edition Published in Circulation 153(17):e1154-e1276 (issue date 2026-04-28; electronic publication 2026-03-13). PubMed abstract and bibliographic data only. The guideline text was not read. PubMed lists 2 corrections to the guideline; their text was not read. The publisher field is the journal title as PubMed gives it.) Locator: Abstract, STRUCTURE, sentence 1. Retrieved 2026-10-15T13:48:57Z. Source state: Corrected. Snapshot hash: afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff. How it applies: What the guideline addresses. 3. Background: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (Guideline, edition Published in Circulation 153(17):e1154-e1276 (issue date 2026-04-28; electronic publication 2026-03-13). PubMed abstract and bibliographic data only. The guideline text was not read. PubMed lists 2 corrections to the guideline; their text was not read. The publisher field is the journal title as PubMed gives it.) Locator: CommentsCorrectionsList, two ErratumIn entries. Retrieved 2026-10-15T13:48:57Z. Source state: Corrected. Snapshot hash: afe254bbde1b02392eb1f21622a009069be7cda3eb26453721b5c3ecdb6498ff. How it applies: Shows that corrections exist. What they change is unknown. ## Connected pages - Co-issuer, with the American Heart Association (title): American College of Cardiology (`core:acc`) - Co-issuer, with the American College of Cardiology (title): American Heart Association (`core:aha`) ## Provenance Content hash: ea5fdbd01fe6c7ab0ac2a46d43a4ef33d5bea8ef7ca85dfb7b7c845ce0768068 Last substantive edit: 2026-10-15 Evidence last checked: 2026-10-15